Intratumoral Production of IL-6 in B Cell Chronic Lymphocytic Leukemia and B Lymphomas

References

• Kishimoto T. The biology of interleukin-6. Blood 1989; 74: 1–10
   PubMed Web of Science ®Google Scholar
• Shimizu S., Yoshioka R., Hirose Y., Siugai S., Tachi-bana J., Konda S. Establishment of two interleu-kin 6-dependent human bone marrow-derived myeloma cell lines. J. Exp. Med. 1989; 169: 339–344
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F., Bergui L., Gregoretti M., Gaidano G., Gaboli M., Schena M., Zambonin Zallone A., Mar-chiso P. C. Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood 1991; 77: 2688–2693
   PubMed Web of Science ®Google Scholar
• Bergui L., Schena M., Gaidano G., Riva M., Cali-garis-Scapio F. Interleukin 3 and Interleukin 6 syn-ergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma. J. Exp. Med. 1989; 170: 613–618
   PubMed Web of Science ®Google Scholar
• Zhang X. G., Klein B., Bataille R. Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. Blood 1989; 74: 11–13
   PubMed Web of Science ®Google Scholar
• Anderson K., Jones R. M., Morimoto C., Leavitt P., Barut B. A. Response patterns of purified myeloma cells to hematopoietic growth factors. Blood 1989; 73: 1915–1924
   PubMed Web of Science ®Google Scholar
• Tosato G., Tanner J., Jones K. D., Revel M., Pike S. E. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. J. Virol. 1990; 64: 3033–3041
   PubMed Web of Science ®Google Scholar
• Zhang X. G., Bataille R., Jourdan M., Saeland S., Banch-ereau J., Mannoni P., Klein B. Granulocyte-Macrophage colony-stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells. Blood 1990; 76: 2599–2605
   PubMed Web of Science ®Google Scholar
• Levy Y., Tsapis A., Brouet J. C. Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines. J. Clin. Invest. 1991; 88: 696–699
   PubMed Web of Science ®Google Scholar
• Schwab G., Siegall C. B., Neckers L. M., Nordan R. P. Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266. Blood 1991; 77: 587–593
   PubMed Web of Science ®Google Scholar
• Hitzler J. K., Martinez-Valdez H., Bergsagel D. B., Minden M. D., Messner H. A. Role of interleukin-6 in the proliferation of human multiple myeloma cell lines OCI-Myl to 7 established from patients with advanced stage of the disease. Blood 1991; 78: 1996–2004
   PubMed Web of Science ®Google Scholar
• Tanner J. E., Tosato G. Regulation of B-cell growth and Immunoglobulin gene transcription by interleukin-6. Blood 1992; 79: 452–459
   PubMed Web of Science ®Google Scholar
• Suzuki H., Yasukawa K., Saito T., Goitsuka R., Hase-gawa A., Ohsugi Y., Taga T., Kishimoto T. Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo. Eur. J. Immunol. 1992; 22: 1989–1993
   PubMed Web of Science ®Google Scholar
• Vink A., Coulie P., Warmer G., Renauld J. C., Stevens M, Donckers D., Van Snick J. Mouse plasma-cytoma growth in vivo: enhancement by interleukin-6 and in-hibition by antibodies directed against IL-6 or its receptor. J. Exp. Med. 1990; 172: 997–1000
   PubMed Web of Science ®Google Scholar
• Tohyama N., Karasuyama H., Tada T. Growth autonomy and tumorigenicity of interleukin-6-dependent B cells transfected with interleukin-6 cDNA. J. Exp. Med. 1990; 171: 389–400
   PubMed Web of Science ®Google Scholar
• Klein B., Wijdenes J., Zhang X. G., Jourdan M., Boiron J. M., Brochier J., Liautard J., Merlin M., Clement C., Morel-Fournier B., Lu Z. Y., Mannoni P., Sany S., Bataille R. Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood 1991; 78: 1198–1204
   PubMed Web of Science ®Google Scholar
• Biondi A., Rossi V., Bassan R., Barbui T., Bettoni S., Sironi M., Mantovani A., Rambaldi A. Constitutive expression of the interleukin-6 gene in chronic lym-phocytic leukemia. Blood 1989; 73: 1279–1284
   PubMed Web of Science ®Google Scholar
• Peuchmaur M., Emilie D., Crevon M. C., Solal-Celigny P., Maillot M. C., Lemaigre G., Galanaud P. IL-2 mRNA expression in Tac-positive malignant lympho-mas. Am. J. Pathol. 1990; 136: 383–390
   PubMed Web of Science ®Google Scholar
• Peuchmaur M., Emilie D., Crevon M. C., Brousse N., Gaulard P., D'Agay M. F., Galanaud P., Solal-Celigny P. Interleukin-2 and Interferon-gamma production in follicular lymphomas. Am. J. Clin. Pathol. 1991; 95: 55–62
   PubMed Web of Science ®Google Scholar
• Devergne O., Raphael M., Autran B., Coumbaras J., Rea D., Crevon M. C., Galanaud P., Emilie D. In-tratumoral activation of CD8+ cytotoxic lymphocytes in AIDS lymphomas. 1993, Submitted for publication
   Google Scholar
• Leger-Ravet M. B., Devergne O., Peuchmaur M., Brousse N., Gaulard P., Solal-Celigny P., Galanaud P., Emilie D. In situ activation of cytotoxic cells in follicular lymphomas. 1993, Submitted for publication
   Google Scholar
• Emilie D., Peuchmaur M., Crevon M. C., Maillot M. C., Brousse N., Delfraissy J. F., Dormont J., Galanaud P. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J. Clin. Invest. 1990; 86: 148–159
   PubMed Web of Science ®Google Scholar
• Leger-Ravet M. B., Peuchmaur M., Devergne O., Au-douin J., Raphael M., Van Damme J., Galanaud P., Die-bold J., Emilie D. Interleukin-6 gene expression in Castleman's disease. Blood 1991; 78: 2923–2930
   PubMed Web of Science ®Google Scholar
• Emilie D., Coumbaras J., Raphael M., Devergne O., De-lecluse H. J., Gisselbrecht C, Michiels J. F., Van Damme J., Taga T., Kishimoto T., Crevon M. C., Galanaud P. Interleukin-6 production in high grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients. Blood 1992; 80: 498–504
   PubMed Web of Science ®Google Scholar
• Jogeeswaran G. Cell surface glycolipids and glyco-proteins in malignant transformation. Adv. Cancer Res. 1983; 38: 289–294
   PubMed Web of Science ®Google Scholar
• Klein B., Zhang X. G., Jourdan M., Content J., Houssiau F., Aarden L., Piechaczyk M., Bataille R. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 1989; 73: 517–526
   PubMed Web of Science ®Google Scholar
• Portier M., Rajzbaum G., Zhang X. G., Attal M., Rusalen C., Wijdenes J., Mannoni P., Maraninchi D., Piechaczyk M., Bataille R., Klein B. In vivo interleukin-6 gene expression in the tumoral environment in multiple myeloma. Eur. J. Immunol. 1991; 21: 1759–1762
   PubMed Web of Science ®Google Scholar
• Portier M., Ursule E., Emilie D., Simony J., Bataille R., Klein B. IL-1 gene expression in multiple myeloma: an in situ analysis. 1993, Submitted for publication
   Google Scholar
• Kawano M., Tanaka H., Ishikawa H., Nobuyoshi M., Iwato K., Asaoku H., Tanabe O., Kuramoto A. Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma. Blood 1989; 73: 2145–2148
   PubMed Web of Science ®Google Scholar
• Mannel D. N., Jänicke R. Induction of monokine production by tumor cells. Lymphok. Res. 1989; 8: 257–269
   PubMedGoogle Scholar
• Janicke R., Männel D. N. Distinct tumor cell membranes constituents activate human monocytes for tumor necrosis factor synthesis. J. Immunol. 1990; 134: 1144–1150
   Google Scholar
• Emilie D., Crevon M. C., Cohen-Kaminsky S., Peuchmaur M., Devergne O., Berrih-Aknin S., Galanaud P. In situ production of interleukins in hyperplastic thy-mus from myasthenia gravis patients. Human Pathol. 1991; 22: 461–468
   PubMed Web of Science ®Google Scholar
• Bosseloir A., Hooghe-Peters E. L., Heinen E., Cormann N., Kinet-Denoel C, Vanhaelst L., Simar L. Localization of interleukin-6 mRNA in human tonsils by in situ hybridization. Eur. J. Immunol., 19: 2379–2385
   PubMed Web of Science ®Google Scholar
• Mazars G. R., Portier M., Zhang X. G., Jourdan M., Bataille R., Theillet C., Klein B. Mutations of the p53 gene in human myeloma cell lines. Oncogenes 1992; 7: 1015–1018
   PubMed Web of Science ®Google Scholar
• Portier M., Molés J. P., Mazars G. R., Jeanteur P., Bataille R., Klein B., Theillet C. p53 and RAS gene mutations in multiple myeloma. Oncogene 1991; 7: 2539–2543
   Web of Science ®Google Scholar
• Emilie D., Touitou R., Raphael M., Peuchmaur M., Devergne O., Rea D., Coumbaras J., Crevon M. C., Edel-man L., Joab I., Galanaud P. In vivo production of IL-10 by malignant cells in AIDS lymphomas. Eur. J. Immunol. 1992; 22: 2937–2942
   PubMed Web of Science ®Google Scholar